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Objective. To determine the association between Yang-Deficient Constitution and the clinical outcomes of HIV/AIDS patients
who have initiated highly active antiretroviral therapy (HAART). Method. A total of 197 antiretroviral-naive adults who initiated
HAART between 2009 and 2011 were recruited. The participants were asked to complete a questionnaire twice to assess their
Yang-Deficient Constitution status before HAART. During the study, signs and symptoms and CD4 or CD8 T cell counts were
recorded. Routine blood and biochemical tests were conducted. For the patients who were found to have infections, pathologic
examination was performed. Statistical test of association of clinical attributes and demographic factors with Yang-Deficient
Constitution was conducted. Result. Good test-retest reliability was observed for Yang-Deficient Constitution scoring.The median
Yang-Deficient Constitution score of 142 eligible participants was 25. Female (score = 32.14, 𝑃 < 0.05), hepatotoxicity (32.14,
𝑃 < 0.1), nephrotoxicity (37.50, 𝑃 < 0.1), total number of adverse events (𝑃 < 0.1), and mortality (39.29, 𝑃 < 0.05) were
associated with Yang-Deficient Consitution, while annual changes or nadir values of CD4 or CD8 T lymphocytes, and newly
acquired infections after starting HAART were not. Mortality was also associated with total number of adverse events (𝑃 < 0.05),
hepatotoxicity (𝑃 < 0.05), and nephrotoxicity (𝑃 < 0.05). Conclusion. Yang-Deficient Constitution score has a potential to be
developed as a predictor for early HIV-related mortality and side effects. The interrelation and underlying mechanisms should be
further investigated for evidence-based design of a more appropriate treatment strategy.
1. Introduction
After China’s National Free Antiretroviral Treatment Pro-
gram has been initiated since 2002, the rate of receiving
antiretroviral therapy cases among the eligible HIV infection
reached 84% nowadays. Although the mortality rate has
decreased to 50% (𝑛 = 17740) for the 34,157 new infections
of HIV, according to the 2012 report by the National Health
and Family Planning Commission of the People’s Republic of
China, AIDS is still the top death-causing disease. Many of
the newly admitted cases of HIV infections are indeed in the
end stage of AIDS. Poor immunological response and adverse
events are also common during initial highly active antiretro-
viral therapy (HAART). These partially account for early
death in the first year of HAART [1].
Individual differences are known to have important
impact on the progression of diseases. In particular, differ-
ences in the composition of genome account for many of
the variations observed and more evidence is emerging that
much of the wisdom of traditional medicine can in fact be
explained at genomics level (Joshi et al. [2] and the references
therein). Recently, HLA class II polymorphisms were found
associatedwith the physiologic characteristics defined byTra-
ditional Chinese Medicine (TCM) [3]. In TCM, constitution
is believed to be a distinct characteristic of an individual [4].
Constitution has been used to guide disease prevention,
health care, and medical practice [5]. Yang-Deficient Con-
stitution is one of the major constitutions, which is charac-
terized by chills, cold limbs, and also spontaneous sweating;
2 Evidence-Based Complementary and Alternative Medicine
Table 1: The measuring scale for Yang-Deficient Consitution of Traditional Chinese Medicine.
Experience/condition in the past year Never Sometimes Often Usually Always
(1) Do you feel cold at your limbs? 1 2 3 4 5
(2) Are you sensitive to cold at stomach, back, waist, or laps? 1 2 3 4 5
(3) Are you usually sensitive to cold weather and dress more than others? 1 2 3 4 5
(4) Are you more sensitive to cold air (such as outside of winter, air-conditioning, or electric fan)? 1 2 3 4 5
(5) Do you have flu- or cold-like symptoms more frequently or easily than others? 1 2 3 4 5
(6) Do you feel uncomfortable or worried for cold water or foods? 1 2 3 4 5
(7) Do you have pulpy bowel after having cold water or foods? 1 2 3 4 5
loose tools and/or profuse clear urine; and lassitude. Recently,
the molecular mechanisms of Yang-Deficient Constitution
[6] have been studied, bridging the gap between conven-
tional wisdom and knowledge gained frommodern scientific
advance. Different types of constitution may be related to
specific lifestyle or diet habits [7] andmanifest corresponding
psychological characteristics of personality [8]. People of
balanced constitution have better quality of life than those of
imbalanced constitution [9]. Moreover, imbalanced constitu-
tion seemed to have strong correlation with chronic diseases
such as obesity [10] and hypertension [11].
Since the last few years before the initiation of this study,
we have been observing that HIV-infected patients of Yang-
Deficient constitution are more likely to die in spite of receiv-
ing HAART. Yang deficiency Syndrome indeed appeared in
many emergency and serious diseases, including the late
stage of AIDS. Processed aconite root (a Chinese medicine)
was shown to prevent cold-stress-induced hypothermia and
immunosuppression in mice [12]. Higenamine and its enan-
tiomer, the active ingredients of aconite root, reduced iNOS
expression and NO production, suppressed inflammatory
reactions, and increased survival rates in LPS-treated mice
[13, 14]. Herbal composite formulae injection with aconite
being the active ingredient was proved to protect the impor-
tant organs during emergency and serious diseases [15–17].
We also found that aconite appears to alleviate the symptoms
complained by our patients. We hypothesize that Yang-
Deficient Constitution is associated with the prognosis of
AIDS. To systematically investigate whether there is any
association between Yang-Deficient Constitution and com-
plications incurred fromHIV infection and design evidence-
based treatment, we conducted a prospective observational
study for evaluating the association between Yang-Deficient
Constitution and clinical outcomes.
2. Method
2.1. Study Population and Design. Treatment-naive HIV-1
infected patients aged 18 years or older at the Guangzhou 8th
People’s Hospital between January 1, 2010, and May 1, 2012,
who joined the National Free Antiretroviral Treatment Pro-
gram with a combination of at least three drugs, includ-
ing NRTIs, PIs, and NNRTIs, were enrolled. Subjects were
excluded if they were pregnant or unable to understand or
finish the questionnaire due to linguistic or mental problems.
All subjects received a full explanation of the study and
provided written informed consent. The study was approved
Table 2: Routine blood and biochemical tests conducted and their
normal range.
Index Normal range Unit
Leukocyte 4–10 10E9/L
Neutrophils 2–7.5 10E9/L
Hemoglobin 120–160 g/L
Platelet 100–300 10E9/L
Seralbumin 35–55 g/L
Alkaline phosphatase 40–150 U/L
Total bilirubin 5.1–22.2 𝜇mol/L
Aspartate transaminase 5–40 U/L
Glutamic-oxaloacetic transaminase 5–40 U/L
Glucose 3.9–6.1 mmol/L
Cholesterol 3.1–6.0 mmol/L
Low density lipoprotein cholesterol 0–3.36 mmol/L
Triglyceride 0.79–1.70 mmol/L
Sarcosine kinase 26–174 U/L
Creatinine 44–133 𝜇mol/L
Pancreatic amylase 22–210 U/L
Lactate 0.6–2.2 mmol/L
by ethics committees ofGuangzhou 8thPeople’sHospital.The
recruited patients were asked to complete the constitution
questionnaire before the initiation ofHAART.Theywere then
scheduled follow-up visits once every 3 months. This study
period was one year and the dropouts were also excluded.
We adopted the definitions published by Centers for
Disease Control and Prevention revision of the AIDS in 1993
case definition (1993 Revised Classification System for HIV
Infection and Expanded Surveillance Case Definition for
AIDS Among Adolescents and Adults, http://www.cdc.gov/
mmwr/preview/mmwrhtml/00018179.htm). People without
an AIDS defining disease but with a CD4 cell count below
200 cells/L were classified as having AIDS.
We adopted the Standards of Classification and Deter-
mination of Constitution of Chinese Medicine issued by the
China Association of Traditional Chinese Medicine in 2009,
which includes theClassification andDetermination of Yang-
Deficient Constitution Scale (see Table 1). The original stan-
dardized questionnaire had been published in 2006 [18],
which was then evaluated and proved to be effective in assess-
ment on the constitution of healthy people and patients [19,
20]. Table 1 shows theEnglish version translated by our group.
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Table 3: Absolute differences between the raw scores over the two time points.
(a)
Absolute raw score difference Frequency
Q1 Q2 Q3 Q4 Q5 Q6 Q7
0 115 105 118 100 107 116 107
1 32 38 20 37 39 27 38
2 9 15 14 17 10 11 11
3 2 6 2 2 3 2
4 2 1
(b)
Total absolute raw score difference Frequency
0 61
1 11
2 14
3 11
4 12
5 15
6 12
7 7
8 6
9 1
10 2
11 3
13 2
16 1
During the interview, the interviewees were given a Chinese
version to complete.The patients were also requested to com-
plete this questionnaire again after the first interview to assess
the reliability of their response. Raw sum scores were cal-
culated for the constitution, and then the sum scores were
converted to a conversion score on a 0-to-100 scale.
2.2. Sociodemographics, Drug Regimen, and Clinical Outcome
Measures. We investigated gender, age, Yang-Deficient Con-
stitution score, survival, HIV disease staging according to
the definition by CDC, Highly Active Antiretroviral Therapy
Medicine (3TC, AZT, D4T, EFV, NVP, KALETRA, and
TDF), CD4 and CD8 count at baseline and 3, 6, 9, and 12
months after HAART, infections acquired before and after
HAART (hepatitis B, hepatitis C, pulmonary tuberculosis,
extrapulmonary tuberculosis, pneumonia, superficial fungal
infections, visceral fungal infections, intestinal infections,
encephalitis and meningitis, and sexually transmitted dis-
ease), immune reconstitution inflammatory syndrome, the
number of days after HAART initiation for an infection to
occur, adverse events including fatigue, allergy, alopecia, gas-
trointestinal reaction, mouth epithelium ulcer and pharyn-
gitis, cerebral symptom, arthralgia, diabetes, hematologic
toxicity, hepatotoxicity, abnormal lipid metabolism, pancre-
atitis, nephrotoxicity, sensory nerve dysfunction, and hyper-
lactacidemia, and total number of adverse events.The routine
blood and biochemical tests conducted and their normal
range are shown in Table 2. Attributes that had fewer than
10% of unique values relative to the number of samples and
the ratio of the frequency of the most common value to the
frequency of the second most common value larger than
(95 : 5) were regarded as low variance attributes and discarded
unless otherwise specified.
2.3. Data Management and Analysis. Reliability of duplicate
tests was evaluated. To assure quality, patients were requested
to complete the same questionnaire twice in two visits
(separated by one week) and the absolute differences of the
scores between the two visits were calculated. Local outlier
factor (LOF), an algorithm for identifying density-based local
outliers [21], was used to filter the unreliable data. Data errors
and problems were identified and sent to clinical doctors for
review.The remaining subjects then had CD4 and CD8 count
and other relevant clinical information recorded. Sixteen
clusters were used to classify the patterns in CD4 and CD8
reconstitution to represent increase or decrease for the tran-
sition between 0, 3, 6, 9, and 12 months after the initiation of
HAART. Statistical analyses and self-organizing map were
done by R (version 2.15.2).
3. Result
We recruited 197 HIV/AIDS patients but only 158 of whom
completed the questionnaire twice. There was no difference
between test-retest scores for two-third of the cases and about
90%with 1 or fewer (Q1: 147, Q2: 143, Q3: 138, Q4: 137, Q5: 146,
Q6: 143, andQ7: 145) absolute score difference (Table 3). Nine
of these subjects having total absolute score difference larger
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Table 4: Characteristics of 142HIV patients.
Category Frequency/median
Gender
Male 96
Female 46
Age 35
Yang-Deficient Constitution score 25
HIV disease staging
A 57
B 16
C 69
Mortality 5
CD4 count
Baseline 113
3 months after HAART 202
6 months after HAART 206
9 months after HAART 229
12 months after HAART 269
CD8 count
Baseline 678.5
3 months after HAART 837
6 months after HAART 836
9 months after HAART 861
12 months after HAART 934
Highly active antiretroviral therapy
3TC 142
AZT 45
D4T 95
EFV 71
NVP 62
KALETRA 7
TDF 1
Infection status before starting HAART
Presence of infection before starting
HAART 50
Hepatitis B 16
Hepatitis C 19
Pulmonary tuberculosis 30
Extrapulmonary tuberculosis 12
Pneumonia 42
Superficial fungal infections 37
Visceral fungal infections 31
Intestinal infections 10
Encephalitis and meningitis 5
Sexually transmitted disease 2
Newly acquired infection after HAART
Presence of newly acquired
infection after HAART 29
Pulmonary tuberculosis 1
Table 4: Continued.
Category Frequency/median
Extrapulmonary tuberculosis 6
Pneumonia 7
Superficial fungal infections 2
Visceral fungal infections 6
Intestinal infections 8
Encephalitis and meningitis 2
Other infections 5
Immune reconstitution inflammatory
syndrome (IRIS) 9
Adverse events
Fatigue 18
Allergy 50
Alopecia 1
Gastrointestinal reaction 44
Mouth epithelium ulcer and
pharyngitis 7
Cerebral symptom 26
Arthralgia 3
Diabetes 1
Hematologic toxicity 48
Hepatotoxicity 49
Abnormal lipid metabolism 26
Pancreatitis 0
Nephrotoxicity 11
Sensory nerve dysfunction 17
Hyperlactacidemia 18
Total number of side effects 24
Number of days an infection occurred
after HAART initiation 80
than 8 (9, 10, 11, 13, and 16) were outliners, defined by local
outlier factor. These individuals were thus excluded from
further investigation.
The other 149 patients were assigned scores by taking
average of two visits, along with 39 patients that only com-
pleted once. As a result, there were 188 HIV/AIDS subjects at
the beginning. Some of them dropped out during followups
and finally there were 142 HIV positive individuals for
in-depth analysis, with 57 (40%), 16 (11%), and 69 (49%)
of whom were classified as types A, B, and C, respec-
tively, according to CDC 1993 Revised Classification System
(1993 Revised Classification System for HIV Infection and
Expanded Surveillance Case Definition for AIDS Among
Adolescents and Adults). The details of demographical infor-
mation are summarized in Table 4.
HAART drugs 3TC, KALETRA, TDF, encephalitis and
meningitis, previous diagnosis of sexually transmitted dis-
ease, newly acquired hepatitis B, hepatitis C, pulmonary and
extrapulmonary TB, pneumonia, superficial and visceral fun-
gal infections, alopecia, mouth epithelium ulcer and pharyn-
gitis, arthralgia, diabetes, and pancreatitis were excluded for
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Table 5: (a) Univariate analysis of Yang deficiency in HIV patients. (b) Logistic regression analysis of risk factors for mortality.
(a)
Variable Category Number/IQR Correlation coefficient Yang deficiency median score 𝑃 value∗
Gender Male 96 N/A 22.32 <0.05
Female 46 32.14
Hepatotoxicity Yes 4 9 N/A 32.14 <0.1
No 93 25.00
Nephrotoxicity Yes 11 N/A 37.50 <0.1
No 131 25.00
HIV disease staging
A 57
N/A
23.21
<0.05B 16 34.82
C 69 25.00
Mortality Yes 137 N/A 39.29 <0.05
No 5 25.00
Age N/A 29–41 −0.028 ND 0.74
CD4 Annual change 77–217 −0.028 ND 0.75
Nadir value 19–194 −0.053 ND 0.53
CD8 Annual change −138–510 −0.028 ND 0.74
Nadir value 334–737 −0.13 ND 0.12
Total number of adverse events N/A 1–5 0.16 ND <0.1
∗Wilcoxon rank sum test with continuity correction, Spearman’s rank correlation, and Kruskal-Wallis rank sum test were performed where appropriate.
(b)
Variable Alive Dead 𝑃 OR OR 95% CI
Previous pneumonia No 99 1 <0.05 10.42 1.48, 207.38
Yes 38 4
Intestinal infections No 131 3 <0.05 14.55 1.69, 106.00
Yes 6 2
IRIS No 130 3 <0.05 12.38 1.46, 87.72
Yes 7 2
Total number of newly acquired infections after HAART N/A N/A N/A <0.05 1.63 1.20, 2.41
Hepatotoxicity No 92 1 <0.05 8.18 1.17, 162.48
Yes 45 4
Nephrotoxicity No 129 2 <0.05 24.19 3.55, 205.36
Yes 8 3
Total number of adverse events N/A N/A N/A <0.05 7.85 1.35, 149.63
further analyses due to their low variance. Other attributes
that were not significantly associated (𝑃 > 0.1) with Yang
deficiency were also excluded.
Compared to males females showed significantly more
serious Yang deficiency (Table 5(a)), but age was not corre-
lated with Yang deficiency. Yang deficiency was also associ-
ated with hepatotoxicity, nephrotoxicity, and the total num-
ber of side effects. Yang deficiencywas neither associatedwith
annual change nor Nadir value of CD4 or CD8 count. We
also performed profile analysis for CD4+ and CD8+ T cell
reconstitution by self-organizing map (Figure 1). Association
was neither identified in CD4 (Kruskal-Wallis rank sum test
𝑃 = 0.54) nor CD8 (Kruskal-Wallis rank sum test 𝑃 = 0.34)
reconstitution pattern (all the 16 clusters) with Yang defi-
ciency. Yang deficiency was associated with both HIV disease
staging and mortality.
There were 5 deaths in this study, due to pneumonia,
infectious diarrhea, extrapulmonary tuberculosis, meningi-
tis, encephalitis, and multiple organ dysfunction syndrome.
The mortality rate was 3.5% (95% CI: 1.4%–8.6%). Indeed,
the total number of newly acquired infections after starting
HAART, previous pneumonia, intestinal infections, and IRIS
and total number of the adverse events, particularly syn-
dromes of hepatotoxicity and nephrotoxicity, were associated
with mortality (Table 5(b)).
4. Discussion
Since the introduction of HAART in 2002 AIDS mortality
(with and without receiving HAART) has begun to decrease
from 39.2 to 14.2 per 100 person-years in 2009 in China [22].
In this study, the mortality rate during the first 12 months
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Figure 1: Change of CD4 and CD8 count over a one-year period during receiving HAART. ((a), (b)) units for the scale prototypic CD4 (a)
and CD8 (b) change and the number of cases assigned. ((c), (d)) Convergence was attained at about the 50th iteration for both CD4 and CD8
profile analyses.
after HAART initiation was 3.5 deaths per 100 person-years,
similar to the national statistics of 4.9 [1]. The causes of death
in our patientswere all AIDS-related diseases, similar to those
reported in low- and middle-income countries [23].
In resource-limited settings, prioritization allows better
allocation of resources for diagnostic tests and appropriate
and timely health services. AIDS patients with low CD4+ cell
counts incur higher expenditures in the first year of antiretro-
viral treatment, due to high incidence of adverse drug events
and opportunistic infections. Annual costs of AIDS patients
with opportunistic infections were 10 times higher than those
of HIV infection alone [24], hardly adequately covered by
public funding. Moreover, over half of the HIV-infected indi-
viduals live in the rural areas of China, according to the 2011
estimates for the HIV/AIDS epidemic in China by National
Center for AIDS/STD Control and Prevention, China CDC.
Public funding accounts for over 90% of all HIV/AIDS
expenditures in the rural areas [25]. In rural settings, where
trained personnel, facilities, and budget are all limiting, a
self-report questionnaire is a possible option. Public health
practitioners collect information usually by various ways and
examine patients by signs and symptoms for diagnosis in
order to design appropriate course of treatment and medica-
tions. More than 80% of respondents successfully completed
the questionnaire twice in this study. Biomarkers have been
extensively investigated as predictors for HIV clinical disease
progression (AIDS or death) over the last two decades [26].
Nevertheless, due to equipment and technical limitations, the
use of these biomarkers was no more efficient than CD4 cell
count. Nevertheless, baseline CD4 cell count was a necessary
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but not sufficient condition for mortality. Poor CD4 cell
reconstitution also did not definitely lead to death (Figure 1;
two left topmost patterns). In this context, convenient and
noninvasive, questionnaire-derivedYang-Deficient Constitu-
tion score has the potential to be developed as an independent
or accessory predictor for disease progression or clinical
outcomes. Larger-scale validation studies can be conducted
to test its applicability.
Constitution is largely inborn and Yang deficiency is one
of themanifestations. Independent of age, female patients had
higher Yang-Deficient Constitution score, which alludes to
possible genetic effects. Our result of the association of female
with Yang-Deficient Consitutionwas consistent with the Yin-
Yang theory in TCM, which says male is characterized by
Yang while female Yin. With regard to age, according to Yel-
low Emperor’s Canon of Traditional ChineseMedicine, Yang-
qi changes along with age, but not in a monotonic manner.
Most of the people recruited in our study were between 20
and 55 years old, change of Yang-qi during this age groupmay
follow a bell-shaped pattern, thus Yang-Deficient Consitution
was proved to have no linear correlationwith age in this study.
Whether the correlation betweenYang-Deficient Consitution
and genderwas due to sex hormonal level needs further eluci-
dation [27, 28]. Malnutrition is also a factor to be considered.
Through a series of statistical tests, we have identified that
Yang-Deficient Constitution was not associated with infec-
tion acquired after starting HAART, low baseline CD4 count,
or CD4 cell reconstitution. However, Yang-Deficient Con-
stitution was associated with death. It should be noted that,
however, death was also associated with infections acquired
after starting HAART. Since Yang-Deficient Constitution did
not appear to predispose the patient to infections, they are
likely to be independent risk factors leading to mortality. In
our study, although HIV disease stage B patients were rela-
tively Yang deficient in general, HIV disease staging was not
the sufficient condition for mortality. Other concurrent con-
ditions might have to satisfy, which ultimately lead to death.
Hepatotoxicity and nephrotoxicity might be the indirect
causes of death of the AIDS patients, which are gener-
ally caused by overlapping anti-infection treatment dur-
ing opportunistic infections. Liver injury can be resulted
from antiretroviral treatment [29], including nonnucleoside
reverse transcriptase inhibitors, which has been widely used
by China’s National Free Antiretroviral Treatment Program.
Antituberculosis drug administration is another common
cause of hepatotoxicity. TB is common co-infectionwithHIV
in China [30] and a national campaign has already been
implemented since 2010 for the prevention and control of
tuberculosis and HIV coinfection. Counter attempts such as
administration of anti-TB drugs are, however, hampered by
hepatotoxicity induced during drug delivery [31]. In our
study, Yang-Deficient Constitution appeared to increase the
risk of antiretroviral or anti-TB drug induced hepatotoxicity.
Nephropathy is another common complication of HIV-
infected individuals. It is also associated with cardiovascular
disease andmortality [32]. During theART-era,HIV [32] and
long-term HAART exposure [33] could be mixed causes for
nephropathy. In our study, antiretroviral agents did not seem
Yang deﬁcient
PLHIV
Opportunistic
infections
Death
HAART/
antibiotics
PLHIV with 
nephrotoxicity/
hepatotoxicity/
cumulative side effects
Figure 2: A hypothesis derived from the key findings about Yang-
Deficient Constitution and clinical outcomes of AIDS patients.
PLHIV: people living withHIV; HAART: highly active antiretroviral
therapy.
to be the reasons of nephrotoxicity, because indinavir, ataza-
navir, and tenofovir disoproxil fumarate (TDF), which have
well-established associations with direct nephrotoxicity sup-
ported by numerous, consistent case reports and large cohort
studies [33], were not used. However, the anti-infection
antibiotics such as foscarnet sodium and amphotericin Bmay
be the causes during cytomegaloviral or fungal infection.
To the best of our knowledge, this is the first report on the
correlation between Yang-Deficient Constitution and hepa-
totoxicity and nephrotoxicity. Mitochondrial toxicity, com-
monly observed in HAART, might be responsible for hepa-
totoxicity and nephrotoxicity [34]. Mitochondrial dynamics
indeed plays a key role in energy conversion andmetabolism,
cell life and death, and disease [35], and various aspects of
metabolism, including lipid, amino acid, and energy metab-
olism, were imbalanced or weakened in Yang deficiency
syndromepatients [36].Whether Yang-DeficientConsitution
is susceptible tomitochondrial toxicity is worth further inves-
tigation. A schematic diagram is shown in Figure 2 to sum-
marize the key finding in this study. Females are prone toYang
deficiency. HIV-infected patients (or people living with HIV,
PLHIV) with a Yang-Deficient Consitution, when adminis-
tered HAART or antibiotics to control HIV replication and
treat infections, may more easily lead to multiple side effects
including nephrotoxicity and hepatotoxicity. When they also
succumb to opportunistic infections, they may eventually
lead to death. It is not known whether HAART/antibiotics or
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opportunistic infections aggravate PLHIV inflicted by toxic
side effects and in turn lead to death.
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